Roche Holding AG (OTCQX International Premier:RHHBY)

41.20
Delayed Data
As of Jan 24
 -1.19 / -2.81%
Today’s Change
25.10
Today|||52-Week Range
42.88
+1.33%
Year-to-Date
Is Biogen Stock a Buy?
Jan 25 / MotleyFool.com - Paid Partner Content
Should Investors Be Worried About Merck's Keytruda?
Jan 23 / MotleyFool.com - Paid Partner Content
Is Mylan Stock a Buy?
Jan 25 / MotleyFool.com - Paid Partner Content
2 Growing Healthcare Stocks You Should Know
Jan 22 / MotleyFool.com - Paid Partner Content
Roche's Tecentriq Fails to Help Patients in Muscle-Invasive Bladder Cancer Trial
Jan 24 / MotleyFool.com - Paid Partner Content
5 Reasons 2020 Will Be a Big Year for Ionis Pharmaceuticals
Jan 16 / MotleyFool.com - Paid Partner Content
Roche's Spinal Muscular Atrophy Drug Meets Primary Endpoint in Infants
Jan 23 / MotleyFool.com - Paid Partner Content
Illumina and Roche Combine For Genomics Oncology Deal
Jan 14 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close42.39
Today’s open42.16
Day’s range41.20 - 42.16
Volume2,152,251
Average volume (3 months)1,473,696
Market cap$228.9B
Data as of 4:00pm ET, 01/24/2020

Growth & Valuation

Earnings growth (last year)+22.19%
Earnings growth (this year)+11.65%
Earnings growth (next 5 years)+5.60%
Revenue growth (last year)+7.27%
P/E ratio24.7
Price/Sales3.68
Price/Book10.05

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$58.1B
Annual profit (last year)$10.7B
Net profit margin18.47%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts